JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+4.92%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$155M
AUM Growth
+$155M
(-6.8%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-15.46%
Top 10 Holdings %
Top 10 Hldgs %
85.83%
Holding
74
New
19
Increased
15
Reduced
20
Closed
15
Top Buys
| 1 |
StoneCo
STNE
|
$17.7M |
| 2 |
XP
XP
|
$11.6M |
| 3 |
NGD
New Gold Inc
NGD
|
$6.5M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.34M |
| 5 |
Inter&Co
INTR
|
$1.31M |
Top Sells
| 1 |
Boyd Gaming
BYD
|
$64.3M |
| 2 |
Nu Holdings
NU
|
$18.1M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$6.99M |
| 4 |
Sigma Lithium
SGML
|
$5.86M |
| 5 |
VanEck Gold Miners ETF
GDX
|
$667K |
Sector Composition
| 1 | Financials | 32.73% |
| 2 | Healthcare | 12.7% |
| 3 | Technology | 11.38% |
| 4 | Materials | 4.47% |
| 5 | Energy | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
UBS Group
UBS
$128B
| $329K | 0.21% |
+10,723
| New | +$329K |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $321K | 0.21% |
333
-484
| -59% | -$466K |
|
28
Molina Healthcare
MOH
$9.8B
| $320K | 0.21% |
778
-132
| -15% | -$54.2K |
|
29
AstraZeneca
AZN
$248B
| $317K | 0.2% |
4,686
-5,080
| -52% | -$344K |
|
30
Amgen
AMGN
$155B
| $301K | 0.19% |
+1,060
| New | +$301K |
|
31
Exxon Mobil
XOM
$487B
| $292K | 0.19% |
+2,513
| New | +$292K |
|
32
State Street
STT
$32.6B
| $288K | 0.19% |
+3,723
| New | +$288K |
|
33
Immunocore
IMCR
$1.62B
| $276K | 0.18% |
4,253
+882
| +26% | +$57.3K |
|
34
Amazon
AMZN
$2.44T
| $276K | 0.18% |
+1,529
| New | +$276K |
|
35
Shell
SHEL
$215B
| $266K | 0.17% |
3,975
| – | – |
|
36
Galicia Financial Group
GGAL
$6.31B
| $254K | 0.16% |
+10,000
| New | +$254K |
|
37
Cigna
CI
$80.3B
| $234K | 0.15% |
643
-207
| -24% | -$75.2K |
|
38
Alamos Gold
AGI
$12.8B
| $228K | 0.15% |
+15,452
| New | +$228K |
|
39
Agnico Eagle Mines
AEM
$72.4B
| $225K | 0.14% |
+3,765
| New | +$225K |
|
40
Novo Nordisk
NVO
$251B
| $214K | 0.14% |
+1,668
| New | +$214K |
|
41
Kymera Therapeutics
KYMR
$2.95B
| $208K | 0.13% |
+5,183
| New | +$208K |
|
42
Becton Dickinson
BDX
$55.3B
| $203K | 0.13% |
822
-557
| -40% | -$138K |
|
43
Itaú Unibanco
ITUB
$77B
| $121K | 0.08% |
+17,483
| New | +$121K |
|
44
Roivant Sciences
ROIV
$8.15B
| $106K | 0.07% |
+10,036
| New | +$106K |
|
45
AbCellera Biologics
ABCL
$1.25B
| $80.5K | 0.05% |
17,779
+362
| +2% | +$1.64K |
|
46
Kodiak Sciences
KOD
$478M
| $78.7K | 0.05% |
14,957
-122
| -0.8% | -$642 |
|
47
BioCryst Pharmaceuticals
BCRX
$1.74B
| $55.2K | 0.04% |
10,865
+215
| +2% | +$1.09K |
|
48
Cerus
CERS
$251M
| $27.5K | 0.02% |
14,539
+308
| +2% | +$582 |
|
|
DBVT
49
DBV Technologies
DBVT
$264M
| $8.92K | 0.01% |
11,907
+249
| +2% | +$187 |
|
|
OIBR.C
50
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $460 | ﹤0.01% |
575,000
| – | – |
|